Institution
Ninewells Hospital
Recent research
- BiologyOpen access
Background: Glioblastoma is a primary aggressive brain tumor, with an average survival rate of ~14.6 months. The low therapeutic benefit of current treatments is in part due to glioblastoma-initiating cells hijacking microglia/macrophages to support tumor growth, prompting the de...
- BiologyOpen access
USP5 acts as a proteolytic switch to control SDE2 function via UBL-directed cleavage
Abstract Proteolytic processing is a fundamental regulatory mechanism in eukaryotic cells, yet the molecular identities and mechanisms underlying such events are often poorly defined. Silencing Defective 2 (SDE2), an essential human protein, plays important roles in mRNA splicing...
- Health & MedicineOpen access
BackgroundAging causes declines in cognitive and motor functions, often manifested in altered gait. Dual-task gait is a sensitive marker for early functional changes. This study investigated whether neural network (NN) models can differentiate gait patterns across age groups unde...
- Health & Medicine
Anticoagulation and Antiplatelet Therapy in Chronic Subdural Hematoma: A Multicenter Evaluation
BACKGROUND AND OBJECTIVES: Chronic subdural hematomas (cSDH) are among the most common neurosurgical pathologies. Older adults also often have comorbidities treated with anticoagulant and antiplatelet (ACAP) medications. Managing clinicians frequently must weigh the benefits and...